Portal hypertension: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Portal hypertension
Classification and external resources

The portal vein and its tributaries.
ICD-10 K76.6
ICD-9 572.3
DiseasesDB 10388
eMedicine radio/570 med/1889
MeSH D006975

In medicine, portal hypertension is hypertension (high blood pressure) in the portal vein and its tributaries.

It is often defined as a portal pressure gradient (the difference in pressure between the portal vein and the hepatic veins) of 5 mm Hg or greater.



Causes can be divided into prehepatic, intrahepatic, and posthepatic. Intrahepatic causes include liver cirrhosis, and hepatic fibrosis (e.g. due to Wilson's disease, hemochromatosis, or congenital fibrosis). Prehepatic causes include portal vein thrombosis or congenital atresia. Posthepatic obstruction occur at any level between liver and right heart, including hepatic vein thrombosis, IVC thrombosis, IVC congenital malformation, and constrictive pericarditis.

Signs and symptoms

Consequences of portal hypertension are caused by blood being forced down alternate channels by the increased resistance to flow through the portal system. They include:



Prophylaxis of variceal bleeding

Both pharamacological(B-blocker and isosorbide mononitrate) and endoscopic(banding ligation) treatment have similar results. TIPS(transjugular intrahepatic portosystemic shunting) is superior to either of them at reducing rate of rebleeding. Disadvantages of TIPS include that it is costly, increase risk of hepatic encephalopathy and does not improve mortality.

Management of active variceal bleeding

After resuscitation, the management of active variceal bleeding include administering vasoactive drugs (somatostatin, octreotide or terlipressin), endoscopic banding ligation, balloon tamponade and TIPS.

Management of ascites

This should be gradual to avoid sudden changes in systemic volume status which can precipitate hepatic encephalopathy, renal failure and death. The management include salt restriction, diuretics(spironolactone), paracentensis, TIPS and peritoneovenous shunt.

Control of hepatic encephalopathy

This include reduction of dietary protein, followed by lactulose, and use of oral antibiotics.


External links


Got something to say? Make a comment.
Your name
Your email address